In vivo efficacy of endothelial growth medium stimulated mesenchymal stem cells derived from patients with critical limb ischemia.
Fiche publication
Date publication
août 2019
Journal
Journal of translational medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr NGUYEN Philippe, Dr TERRYN Christine
Tous les auteurs :
Al-Rifai R, Nguyen P, Bouland N, Terryn C, Kanagaratnam L, Poitevin G, François C, Boisson-Vidal C, Sevestre MA, Tournois C
Lien Pubmed
Résumé
Cell therapy has been proposed for patients with critical limb ischemia (CLI). Autologous bone marrow derived cells (BMCs) have been mostly used, mesenchymal stem cells (MSCs) being an alternative. The aim of this study was to characterize two types of MSCs and evaluate their efficacy.
Mots clés
Angiogenesis, Cell therapy, Critical limb ischemia, Mesenchymal stem cells
Référence
J Transl Med. 2019 Aug 9;17(1):261